あすか製薬ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/05/08 | 1,299 | 1,331 | 1,293 | 1,318 | +27 | +2.1% | 105,700 |
2023/05/02 | 1,295 | 1,300 | 1,283 | 1,291 | -9 | -0.7% | 53,400 |
2023/05/01 | 1,280 | 1,300 | 1,280 | 1,300 | +28 | +2.2% | 84,600 |
2023/04/28 | 1,259 | 1,274 | 1,249 | 1,272 | +27 | +2.2% | 68,100 |
2023/04/27 | 1,249 | 1,254 | 1,231 | 1,245 | -13 | -1% | 59,600 |
2023/04/26 | 1,244 | 1,270 | 1,240 | 1,258 | +5 | +0.4% | 55,600 |
2023/04/25 | 1,243 | 1,259 | 1,242 | 1,253 | +12 | +1% | 56,600 |
2023/04/24 | 1,240 | 1,254 | 1,231 | 1,241 | +13 | +1.1% | 74,100 |
2023/04/21 | 1,215 | 1,240 | 1,198 | 1,228 | +17 | +1.4% | 90,300 |
2023/04/20 | 1,213 | 1,225 | 1,200 | 1,211 | -14 | -1.1% | 68,600 |
2023/04/19 | 1,223 | 1,225 | 1,213 | 1,225 | +3 | +0.2% | 44,800 |
2023/04/18 | 1,216 | 1,222 | 1,212 | 1,222 | +13 | +1.1% | 37,600 |
2023/04/17 | 1,220 | 1,223 | 1,206 | 1,209 | -1 | -0.1% | 43,700 |
2023/04/14 | 1,194 | 1,214 | 1,185 | 1,210 | +22 | +1.9% | 63,400 |
2023/04/13 | 1,188 | 1,194 | 1,180 | 1,188 | -7 | -0.6% | 29,900 |
2023/04/12 | 1,193 | 1,199 | 1,192 | 1,195 | +4 | +0.3% | 24,700 |
2023/04/11 | 1,190 | 1,194 | 1,181 | 1,191 | +5 | +0.4% | 60,800 |
2023/04/10 | 1,189 | 1,193 | 1,180 | 1,186 | +8 | +0.7% | 35,100 |
2023/04/07 | 1,169 | 1,184 | 1,169 | 1,178 | +9 | +0.8% | 29,100 |
2023/04/06 | 1,170 | 1,177 | 1,162 | 1,169 | -9 | -0.8% | 27,000 |
2023/04/05 | 1,194 | 1,194 | 1,172 | 1,178 | -17 | -1.4% | 48,300 |
2023/04/04 | 1,201 | 1,201 | 1,188 | 1,195 | ±0 | ±0% | 42,800 |
2023/04/03 | 1,204 | 1,208 | 1,189 | 1,195 | +6 | +0.5% | 33,600 |
2023/03/31 | 1,173 | 1,195 | 1,168 | 1,189 | +10 | +0.8% | 41,100 |
2023/03/30 | 1,182 | 1,200 | 1,169 | 1,179 | -24 | -2% | 51,600 |
2023/03/29 | 1,184 | 1,203 | 1,179 | 1,203 | +28 | +2.4% | 79,800 |
2023/03/28 | 1,185 | 1,190 | 1,164 | 1,175 | -5 | -0.4% | 47,700 |
2023/03/27 | 1,187 | 1,191 | 1,175 | 1,180 | -6 | -0.5% | 62,900 |
2023/03/24 | 1,160 | 1,186 | 1,155 | 1,186 | +26 | +2.2% | 64,900 |
2023/03/23 | 1,160 | 1,165 | 1,148 | 1,160 | -1 | -0.1% | 36,400 |
2023/03/22 | 1,157 | 1,180 | 1,157 | 1,161 | +34 | +3% | 51,100 |
2023/03/20 | 1,130 | 1,137 | 1,120 | 1,127 | +3 | +0.3% | 57,600 |
2023/03/17 | 1,132 | 1,140 | 1,123 | 1,124 | +3 | +0.3% | 28,700 |
2023/03/16 | 1,107 | 1,124 | 1,104 | 1,121 | -14 | -1.2% | 50,200 |
2023/03/15 | 1,140 | 1,155 | 1,133 | 1,135 | +17 | +1.5% | 45,800 |
2023/03/14 | 1,158 | 1,158 | 1,113 | 1,118 | -52 | -4.4% | 82,400 |
2023/03/13 | 1,185 | 1,185 | 1,161 | 1,170 | -24 | -2% | 46,100 |
2023/03/10 | 1,193 | 1,203 | 1,193 | 1,194 | -8 | -0.7% | 58,100 |
2023/03/09 | 1,186 | 1,205 | 1,185 | 1,202 | +26 | +2.2% | 54,400 |
2023/03/08 | 1,177 | 1,187 | 1,176 | 1,176 | ±0 | ±0% | 42,600 |
2023/03/07 | 1,174 | 1,182 | 1,165 | 1,176 | +16 | +1.4% | 63,900 |
2023/03/06 | 1,161 | 1,164 | 1,146 | 1,160 | +4 | +0.3% | 51,200 |
2023/03/03 | 1,150 | 1,162 | 1,150 | 1,156 | +14 | +1.2% | 36,200 |
2023/03/02 | 1,137 | 1,152 | 1,137 | 1,142 | +5 | +0.4% | 29,500 |
2023/03/01 | 1,137 | 1,142 | 1,135 | 1,137 | ±0 | ±0% | 39,800 |
2023/02/28 | 1,140 | 1,145 | 1,135 | 1,137 | -7 | -0.6% | 38,500 |
2023/02/27 | 1,150 | 1,154 | 1,143 | 1,144 | -10 | -0.9% | 38,100 |
2023/02/24 | 1,168 | 1,168 | 1,151 | 1,154 | -14 | -1.2% | 41,400 |
2023/02/22 | 1,175 | 1,178 | 1,168 | 1,168 | -11 | -0.9% | 35,500 |
2023/02/21 | 1,176 | 1,184 | 1,174 | 1,179 | -4 | -0.3% | 25,200 |
551~
600
件表示中 / 1062件
類似銘柄と比較する
現在ご覧いただいている「あすかHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
あすかHD | 246,300円 | +16.9% | +33.2% | 2.23% | 13.43倍 | 1.07倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
ハートシード | 355,500円 | +174.2% | - | 0.00% | - | 10.76倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
JCRファーマ | 60,000円 | +14.3% | - | 3.33% | 24.39倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
ヘリオス | 63,700円 | +150.0% | - | 0.00% | - | 33.79倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
タウンズ | 53,100円 | +4.6% | +6.1% | 5.27% | 9.06倍 | 3.36倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
市場注目の銘柄
チャート関連のコラム